Yong Yang

TL;DR: In this article , the authors examined whether Gut microbiota plays a role in the beneficial effects of (R)-ketamine in the reduced bone mineral density (BMD) of OVX mice, which is an animal model of postmenopausal osteoporosis.

TL;DR: In this article , the authors investigated whether (R)-ketamine could affect demyelination in CPZ-treated mice and remyelification after CPZ withdrawal, and they found that repeated treatment with (R]-ketamine (10 mg/kg/day, twice weekly, for 6 weeks) significantly ameliorated demyeling and activated microglia in the brain compared with saline-treated mouse.

TL;DR: In this paper , the authors investigated whether subdiaphragmatic vagotomy (SDV) could affect depression-like behaviors, abnormal composition of gut microbiota, and microbes-derived metabolites in Chrna7 KO mice.

TL;DR: Gut microbiota may play a role in the microglial activation in the mPFC and NAc of adult mice after repeated WIN55,212–2 exposure during adolescence, and it is likely that gut–microbiota–microglia crosstalk might play a roles in increased risk for psychosis in adults with cannabis use during adolescence.

TL;DR: In this article , the authors investigated whether sub-diaphragmatic vagotomy (SDV) affects demyelination in CPZ-treated mice and found that SDV significantly ameliorated demyelin and microglial activation in the brain compared with sham-operated CPZ treated mice.